Bender Robert & Associates
MRK icon

Bender Robert & Associates’s Merck MRK Stock Holding History

Bender Robert & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,343
Closed -$661K – 67
2024
Q2 		$661K Buy
+5,343
New +$688K 0.15% 30

Other funds holding MRK

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Bender Robert & Associates's MRK Position: Q3 2026 in Review

Bender Robert & Associates increased its Merck (MRK) stake by 4.2% in Q3 2026, buying an estimated $23.2K and bringing the position to 4,210 shares worth $612K. The position accounts for 0.12% of the portfolio, ranked #33.

Bender Robert & Associates first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $953K in Q4 2022. 3,520 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Bender Robert & Associates held 4,210 shares of Merck worth $612K as of Q3 2026.
  • Bender Robert & Associates bought 168 Merck shares in Q3 2026, an estimated $23.2K.
  • Merck made up 0.12% of Bender Robert & Associates's portfolio in Q3 2026, its #33 holding.
  • Bender Robert & Associates first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Bender Robert & Associates's Merck position peaked at $953K in Q4 2022.
  • 3,520 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Bender Robert & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.